Eyerising Myopia Management Device, a breakthrough in myopia control, specially developed for children.

Introducing the Eyerising Myopia Management Device, a breakthrough in myopia control, specially developed for children. Using patented Repeated Low-Level Red-Light therapy, this device is a game-changer in the field of ocular health. This innovative technology works by gently stimulating blood flow in the ocular fundus. This alleviates sclera hypoxia, controlling the axial lengthening that causes myopia. It offers child-friendly approach that promises not just treatment but transformation. The Eyerising Myopia Management Device is more than just an intervention; it's an opportunity. It offers earlier treatment, more options, and the potential for RLRL as a new adjunct therapy. With this device, practitioners can now have a more comprehensive approach to myopia management. Through our partnership, Abdul Latif Jameel Health is set to bring this life-changing technology to those who need it most, ensuring a brighter future and clearer vision for children across the Global South